Cinacalcet Hcl
Brand name: Cinacalcet Hcl
Rank #302 of 500 drugs by total cost
$37.9M
Total Cost
76,761
Total Claims
$37.9M
Total Cost
2,920
Prescribers
$493
Cost per Claim
6,424
Beneficiaries
118,668
30-Day Fills
$13K
Avg Cost/Provider
26
Avg Claims/Provider
About Cinacalcet Hcl
Cinacalcet Hcl (sold as Cinacalcet Hcl) was prescribed 76,761 times by 2,920 Medicare Part D providers in 2023, costing the program $37.9M. At $493 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 299 | Icatibant Acetate (Icatibant) | $38.4M | 831 |
| 300 | Dextroamphetamine/Amphetamine (Dextroamphetamine-Amphetamine) | $38.2M | 706,329 |
| 301 | Nebivolol Hcl (Nebivolol Hcl) | $38.2M | 421,756 |
| 302 | Cinacalcet Hcl (Cinacalcet Hcl) | $37.9M | 76,761 |
| 303 | Risperidone (Risperidone) | $37.4M | 1,480,207 |
| 304 | Prednisone (Prednisone) | $37.3M | 5,970,737 |
| 305 | Tacrolimus (Tacrolimus) | $37.1M | 175,053 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology